Veeva Systems

Shares of medical cloud software firm Veeva Systems (VEEV)  were falling almost 6% on Tuesday afternoon after noted short seller Citron Research tweeted a short recommendation on the stock.

$VEEV price target $65. Competition has arrived as multiple is at peak and short interest at low. Same setup as $NVDA at $280. A market correction will hit $VEEV harder than any other SaaS name. Buyout off the table until $40

— Citron Research (@CitronResearch) December 4, 2018

Veeva shares began the day trading at about $99 and were already falling when Citron published a tweet setting a price target of $65, saying that a "a market correction will hit $VEEV harder than any other SaaS name." Selling accelerated after the tweet, before recovering some ground. The broader markets were down about 3% on Tuesday on concerns about the U.S.-China trade deal and concerns over economic growth. 

Citron likened Veeva's position to chipmaker Nvdia (NVDA) , which hit a closing high of $289 on Oct. 1 before plummeting to $159 currently. 

Veeva is still up almost 70% this year. 

More from Investing

Global Stocks Mixed as China GDP Slows, Brexit Uncertainty Hangs Over Europe

Global Stocks Mixed as China GDP Slows, Brexit Uncertainty Hangs Over Europe

US Earnings Season Off to Solid Start, But 2019 Growth Rate Set to Slow Sharply

US Earnings Season Off to Solid Start, But 2019 Growth Rate Set to Slow Sharply

Takeda Pharmaceutical CEO Talks Big Pharma Trends

Takeda Pharmaceutical CEO Talks Big Pharma Trends

Why Bankrate's CFA Expects Two More Rate Hikes in 2019

Why Bankrate's CFA Expects Two More Rate Hikes in 2019

Norwegian Cruise Lines Could Be Docking With a Dividend in 2019

Norwegian Cruise Lines Could Be Docking With a Dividend in 2019